IRulya Therapeutics (IRLA) Enterprise Value: 61.34M

IRulya Therapeutics, Inc. (IRLA)

32.95 +1.33 (+4.21%) USD | NASDAQ | Oct 30, 16:00

33.50 +0.55 (+1.67%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2019. Start Trial.

Date	Value
October 30, 2026	61.34M
October 29, 2026	59.99M
October 28, 2026	61.35M
October 27, 2026	60.86M
October 26, 2026	59.75M
October 23, 2026	61.48M
October 22, 2026	61.22M
October 21, 2026	63.10M
October 20, 2026	68.79M
October 19, 2026	62.87M
October 16, 2026	60.41M
October 15, 2026	61.63M
October 14, 2026	58.34M
October 13, 2026	56.18M
October 12, 2026	60.78M
October 09, 2026	60.10M
October 08, 2026	57.69M
October 07, 2026	55.01M
October 06, 2026	55.10M
October 05, 2026	56.41M
October 02, 2026	57.53M
October 01, 2026	59.03M
September 30, 2026	59.37M
September 29, 2026	59.53M
September 28, 2026	57.33M

Date	Value
September 25, 2026	59.36M
September 24, 2026	58.34M
September 23, 2026	58.50M
September 22, 2026	59.72M
September 21, 2026	59.36M
September 18, 2026	57.81M
September 17, 2026	55.30M
September 16, 2026	55.46M
September 15, 2026	57.17M
September 14, 2026	56.91M
September 11, 2026	57.89M
September 10, 2026	57.29M
September 09, 2026	58.66M
September 08, 2026	57.83M
September 04, 2026	59.69M
September 03, 2026	58.90M
September 02, 2026	60.53M
September 01, 2026	60.49M
August 31, 2026	60.96M
August 28, 2026	62.16M
August 27, 2026	60.89M
August 26, 2026	59.68M
August 25, 2026	59.29M
August 24, 2026	61.88M
August 21, 2026	62.34M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks